
#MedTech @bluewindinc closed $47.8M in combined equity and debt to scale commercialization of Revi, its implantable tibial neuromodulation system for urgency urinary incontinence.
📰 Full news: eu1.hubs.ly/H0vltlt0
#Neuromodulation #Urology #Funding #GSCapitalConnect
English